Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel P Haas

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Urology|June 11, 2013
Is penile preservation of distal corporal invasive penile cancer sufficient treatment?Simon Horenblas, Gabriel P Haas
The Canadian Journal of Urology|September 4, 2008
Update on the diagnosis and management of prostate cancerMark LaSpina, Gabriel P Haas
Urology|May 5, 2011
Editorial commentGabriel P Haas, Nicolas Barry Delongchamps
Urologic Oncology|January 27, 2015
A window into new drug development for urologic oncology. Part I: How bench-to-bedside research can result in approvalGabriel P Haas, Howard I Scher
Indian Journal of Urology : IJU : Journal of the Urological Society of India|August 13, 2009
Inspiring urology trainees to enter academic careersGabriel P Haas, Ching Y Wang
Urologic Oncology|March 31, 2015
A window into new drug development for urologic oncology. Part II: Bench-to-bedside research improves survival in urologic cancer, and the discovery of better biomarkers can help predict patient response, toxicity, and resistance to therapyGabriel P Haas, Howard I Scher
The Journal of Urology|July 24, 2012
Editorial commentGabriel P Haas, Nicolas Barry Delongchamps
The Canadian Journal of Urology|October 28, 2014
Temporal trends and racial disparities in global prostate cancer prevalenceTimothy R Rebbeck, Gabriel P Haas
Nature Reviews. Urology|November 11, 2009
Saturation biopsies for prostate cancer: current uses and future prospectsNicolas B Delongchamps, Gabriel P Haas
Cancer Control : Journal of the Moffitt Cancer Center|August 4, 2006
The role of prevalence in the diagnosis of prostate cancerNicolas B Delongchamps, Amar Singh, Gabriel P Haas
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Urology|June 11, 2013
Is penile preservation of distal corporal invasive penile cancer sufficient treatment?Simon Horenblas, Gabriel P Haas
The Canadian Journal of Urology|September 4, 2008
Update on the diagnosis and management of prostate cancerMark LaSpina, Gabriel P Haas
Urology|May 5, 2011
Editorial commentGabriel P Haas, Nicolas Barry Delongchamps
Urologic Oncology|January 27, 2015
A window into new drug development for urologic oncology. Part I: How bench-to-bedside research can result in approvalGabriel P Haas, Howard I Scher
Indian Journal of Urology : IJU : Journal of the Urological Society of India|August 13, 2009
Inspiring urology trainees to enter academic careersGabriel P Haas, Ching Y Wang
Urologic Oncology|March 31, 2015
A window into new drug development for urologic oncology. Part II: Bench-to-bedside research improves survival in urologic cancer, and the discovery of better biomarkers can help predict patient response, toxicity, and resistance to therapyGabriel P Haas, Howard I Scher
The Journal of Urology|July 24, 2012
Editorial commentGabriel P Haas, Nicolas Barry Delongchamps
The Canadian Journal of Urology|October 28, 2014
Temporal trends and racial disparities in global prostate cancer prevalenceTimothy R Rebbeck, Gabriel P Haas
Nature Reviews. Urology|November 11, 2009
Saturation biopsies for prostate cancer: current uses and future prospectsNicolas B Delongchamps, Gabriel P Haas
Cancer Control : Journal of the Moffitt Cancer Center|August 4, 2006
The role of prevalence in the diagnosis of prostate cancerNicolas B Delongchamps, Amar Singh, Gabriel P Haas
Pageof 9